BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 221 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $468,904 | -79.1% | 9,337 | -81.3% | 0.00% | -87.5% |
| Q1 2023 | $2,242,617 | +141300.8% | 49,847 | +37.7% | 0.01% | +33.3% |
| Q4 2022 | $1,586 | -100.0% | 36,211 | -39.1% | 0.01% | -60.0% |
| Q3 2022 | $3,916,000 | -83.1% | 59,430 | -87.0% | 0.02% | -82.6% |
| Q2 2022 | $23,174,000 | +32.1% | 458,806 | +67.0% | 0.09% | +75.5% |
| Q1 2022 | $17,548,000 | +180.9% | 274,707 | +370.9% | 0.05% | +172.2% |
| Q4 2021 | $6,248,000 | -75.3% | 58,333 | -76.3% | 0.02% | -77.8% |
| Q3 2021 | $25,307,000 | +9.7% | 246,151 | -6.1% | 0.08% | +3.8% |
| Q2 2021 | $23,068,000 | +188.4% | 262,259 | +204.0% | 0.08% | +73.3% |
| Q3 2020 | $7,998,000 | +1325.7% | 86,281 | +798.9% | 0.04% | +1025.0% |
| Q1 2020 | $561,000 | +134.7% | 9,599 | +221.3% | 0.00% | +100.0% |
| Q4 2019 | $239,000 | -83.3% | 2,988 | -83.3% | 0.00% | -84.6% |
| Q1 2019 | $1,429,000 | – | 17,846 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |